ELISA – Products

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.

Download this app note to discover an automated SARS-CoV-2 IgG Ab ELISA workflow that delivers stable assay performance across the entire plate and produces more than 1,000 results in 11 hours.

Avacta Group plc is pleased to announce that Avacta Life Sciences’ diagnostics division has achieved ISO 13485 certification for the quality management system for the manufacture and distribution of Affimer reagents for use in lateral flow, ELISA and immunodiagnostic in-vitro diagnostic devices.

AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes.

Assays, such as the enzyme-linked immunosorbent assay (ELISA), are being developed to detect the presence of anti-SARS-CoV-2 antibodies in patient sera. Download this article to discover an ELISA that is more sensitive than a lateral flow immunoassay.

Avacta Group plc has announced that it has entered into a global distribution agreement with ABCAM plc to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.

Download this whitepaper to discover approaches for the detection and quantification of HCPs that streamline the process of impurity monitoring, have broad sample applicability through mass spectrometry and consider patient safety, product stability and purity.